October 3 2016
Posted March 20, 2014
Dr. Rudy Tanzi of Harvard Medical School/Mass General Hospital talks to David Shenk about his research into CD33 inhibitors, which show promise in curtailing the damaging brain inflammation that occurs in Alzheimer’s disease.
October 3 2016
May 19 2014
May 19 2014
May 7 2014